KRT18 and metabolic dysfunction-associated steatotic liver disease: On the other hand, the study conducted by Kravchenko, LS et al. found that hypolipidemic therapy with RSV in patients with NAFLD for 3 months resulted in a significant drop in CK18 levels by 9% (p > 0.05) [82].